The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates

被引:95
|
作者
Clark, Andrew R. [1 ]
Weers, Jeffry G. [2 ]
Dhand, Rajiv [3 ]
机构
[1] Aerogen Pharma Corp, San Mateo, CA USA
[2] Respira Therapeut Inc, Burlingame, CA USA
[3] Univ Tennessee, Grad Sch Med, Dept Med, Div Pulm & Crit Care Med, 1924 Alcoa Highway,U114, Knoxville, TN 37920 USA
关键词
dispersion characteristics; dry powder inhalers; inspiratory flow rate; inspiratory pressure; respiratory review; In-check DIAL; MAXIMAL RESPIRATORY PRESSURES; DOSE DELIVERY PERFORMANCE; PULMONARY DRUG-DELIVERY; LUNG DEPOSITION; TERBUTALINE SULFATE; ASTHMATIC-CHILDREN; NORMAL VALUES; INHALATION; COPD; RESISTANCE;
D O I
10.1089/jamp.2019.1556
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Dry powder inhalers (DPIs) all have the ability to aerosolize dry powders, but they each offer different operating mechanisms and resistances to inhaled airflow. This variety has resulted in both clinician and patient confusion concerning DPI performance, use, and effectiveness. Particularly, there is a growing misconception that a single peak inspiratory flow rate (PIFR) can determine a patient's ability to use a DPI effectively, regardless of its design or airflow resistance. For this review article, we have sifted through the relevant literature concerning DPIs, inspiratory pressures, and inspiratory flow rates to provide a comprehensive and concise discussion and recommendations for DPI use. We ultimately clarify that the controlling parameter for DPI performance is not the PIFR but the negative pressure generated by the patient's inspiratory effort. A pressure drop similar to >= 1 kPa (similar to 10 cm H2O) with any DPI is a reasonable threshold above which a patient should receive an adequate lung dose. Overall, we explore the underlying factors controlling inspiratory pressures, flow rates and dispensing, and dispersion characteristics of the various DPIs to clarify that inspiratory pressures, not flow rates, limit and control a patient's ability to generate sufficient flow for effective DPI use.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [41] Maximal inspiratory flow rates in patients with COPD
    Stanescu, D
    Veriter, C
    Van de Woestijne, KP
    CHEST, 2000, 118 (04) : 976 - 980
  • [42] In vitro testing of two formoterol dry powder inhalers at different flow rates
    Weuthen, T
    Roeder, S
    Brand, P
    Müllinger, B
    Scheuch, G
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2002, 15 (03): : 297 - 303
  • [43] Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild severe asthma and severe COPD
    Jones, Spencer
    Gath, Ingolf
    Weuthen, Thomas
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [44] In-vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: Influence of inspiratory flow rates
    Feddah, MR
    Brown, KF
    Gipps, EM
    Davies, NM
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2000, 3 (03): : 317 - 324
  • [45] Comparisons between In-Check DIAL® and PF810® in evaluation and training inspiratory capacity for using dry powder inhalers
    Wu, Yixing
    Li, Li
    Gong, Ying
    Li, Xingjing
    Ye, Xiaofen
    Zhang, Jing
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [46] Inappropriate Peak Inspiratory Flow Rate with Dry Powder Inhaler in Chronic Obstructive Pulmonary Disease
    Chen, Shih-Yu
    Huang, Chun-Kai
    Peng, Hui-Chuan
    Yu, Chong-Jen
    Chien, Jung-Yien
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [47] Inappropriate Peak Inspiratory Flow Rate with Dry Powder Inhaler in Chronic Obstructive Pulmonary Disease
    Shih-Yu Chen
    Chun-Kai Huang
    Hui-Chuan Peng
    Chong-Jen Yu
    Jung-Yien Chien
    Scientific Reports, 10
  • [48] Inspiratory Flow Volume Of Dry Powder Inhaler And The Relation Of Patients Respiratory Function Or Grip Strength
    Komase, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [49] Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis
    Stass, Heino
    Nagelschmitz, Johannes
    Kappeler, Dominik
    Sommerer, Knut
    Patzlaff, Astrid
    Weimann, Boris
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (03) : 156 - 163
  • [50] Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations
    Martin, Gary P.
    Marriott, Christopher
    Zeng, Xian-Ming
    PHARMACEUTICAL RESEARCH, 2007, 24 (02) : 361 - 369